Agence nationale de sécurité du médicament - activities

Covid vaccine-related menstrual disorder: the cycle extended by one day, a study found

Covid-19 vaccines have caused many menstrual disorders, as shared by many women. Released this January 5, 2022, an American study acknowledges the vaccine can somewhat disturb the menstrual cycle, but effects remain harmless.

Covid: 5 myocarditis cases reported in France after Pfizer vaccine, no connection found so far

The French National Agency for Medicines recently announced that 5 myocarditis cases have been reported in France in people vaccinated with the Pfizer vaccine, but no causal link has been made between the two events so far.

Covid: the French Medicines Agency releases latest data about vaccine side effects

As the vaccination campaign is expected to increase even more in France over the coming weeks, the ANSM – the National Medicines Agency – has unveiled the conclusions of their latest investigation on side effects noticed following Covid-19 vaccination. Keep reading to find out more.

Covid: France has approved two monoclonal antibody therapies

This Monday March 15, the Agence du Médicament (French Medicines Agency) announced that two monoclonal antibody therapies, namely REGN-COV2 and Eli Lilly laboratory's therapy based on bamlanivimab and etesevimab were now approved in France.

Disposable masks soon to be reusable?

Disposable surgical masks and FFP2 masks may soon be reusable. Four French scientists say they have found an effective washing method to sterilize masks and keep their filtration properties. They still have to test this process on a big scale.

Coronavirus: towards medicines shortage in France?

Should France get ready to face medicines shortage? In an interview with Le Figaro, published on April 7, the Agence Nationale de Sécurité du Médicament or French Agency for the Safety of Medicine has said they only have a “fifteen-day” window of visibility for some products. Let’s have a look on the situation.